Business Wire

Opus Trust Marketing Invests in Pitney Bowes’ Technology to Accelerate Growth

Del

Pitney Bowes Inc. (NYSE:PBI), a global technology company providing innovative products and solutions to power commerce, today announced that it has won a contract with Leicester-based Opus Trust Marketing. The contract will help Opus Trust accelerate growth and deliver its ambitious strategic development plans. Opus Trust specialises in multichannel communications, critical document printing and mailing for a diversity of high profile clients, including 20% of the FTSE 100. It is investing in Pitney Bowes’ Pulse™ inserting system as well as two of Pitney Bowes’ high-performance multi format inserters, Epic™.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171017005541/en/

The Pulse™ inserting system (Photo: Business Wire)

The Pulse™ inserting system (Photo: Business Wire)

Opus Trust is also investing its time in Pitney Bowes’ digital customer engagement solutions as part of an Early Adopters programme. This will see it experience the very latest Pitney Bowes solutions prior to their formal launch, with the view of delivering omnichannel services to its clients.

Opus Trust manages high volumes of critical, transactional documents, sending nearly 1,000 communications every minute on behalf of its clients – almost 1.3 million every working day. The Pitney Bowes technologies will extend and enhance the services it can deliver, offering greater reliability through the integration of physical and digital technologies. Pitney Bowes’ Pulse inserting system eliminates the need for manual hand enclosing, instead automating enclosing to improve efficiencies, reduce costs and improve integrity: many of Opus Trust’s clients must adhere to strict regulatory deadlines for on-time billing or face significant penalties. Pulse’s integrity tracking and ‘proof of mail’ features provide Opus Trust and its clients with documented processes, peace-of-mind and a strong foundation for regulatory compliance.

Multi-format inserter Epic will automate manual processes, improve flexibility and increase available capacity to support the continued growth and increase in volumes. Opus Trust can switch between jobs and clients quickly, effectively and securely. Additionally, Epic will accelerate processing speed and boost productivity, crucial during peak times when the volumes of utility bills and year-end financial documents managed by Opus Trust increase by 50%.

Pulse and Epic take residence in Opus Trust’s next-generation print production facility alongside a suite of existing technologies from the Pitney Bowes portfolio, including two flagship Pitney Bowes® IntelliJet printing systems. This latest technology investment demonstrates Opus Trust’s commitment to high-integrity critical document outsourcing.

Paul Brough, CEO at Opus Trust Marketing, said, “Opus Trust is experiencing rapid growth, and we are continuing to invest in new technologies so we can deliver over and above our clients’ expectations, achieving faster processing speeds, high impact physical and digital communications and robust levels of integrity. Our latest investment in Pulse and Epic demonstrates our commitment to delivering an outstanding client experience with connected, intelligent communications, and reflects our strong strategic partnership with Pitney Bowes.” He continues, “We’ve built up an excellent relationship with the Pitney Bowes team over the six years we’ve been working together, and appreciate their professionalism, their in-depth understanding of our business, and their passion for getting it right. We’re looking forward to further collaboration in the future.”

Shemin Nurmohamed, Vice President of DMT Europe for Pitney Bowes said, “Opus Trust is a great success story, staying highly relevant in our digital landscape by delivering multichannel communications and demonstrating a client-first approach. Opus Trust continues to make strategic investments to benefit its clients, and we’re delighted that Paul and the team have selected Pulse and Epic to join its other technologies from the Pitney Bowes family.”

About Opus Trust Marketing

Outsourced communications specialist Opus Trust Marketing produces and distributes fast, secure communications, from physical letters and mailing packs to digital messages via e-delivery, SMS and EDI. Typical documents include letters, statements, invoices, pension documents, share certificates, pay slips and P60s.

The company sends nearly 1,000 communications every minute on behalf of its clients – that’s almost 1.3 million every working day. It can distribute communications to a handful of recipients or millions, and its data processing capabilities mean that messages are tailored specifically for each recipient. Opus Trust offers postal sorting services to reduce clients’ postage costs.

Opus Trust works with organisations across energy, water, financial services, telecoms, business services, travel and leisure, construction and the public sector, and on behalf of 20 per cent of FTSE 100 companies.

Many of Opus Trust’s clients work within highly regulated markets, meaning data management and data security is critical. The company is certified to a number of ISO standards, including Information Security Management and Quality Management. It has proven, rigorous processes and audit trails in place, and its high-security environment ensures personal data is protected at all times.

Opus Trust is headquartered in Leicester. For further information please visit www.opustrust.co.uk.

About Pitney Bowes

Pitney Bowes (NYSE:PBI) is a global technology company powering billions of transactions – physical and digital – in the connected and borderless world of commerce. Clients around the world, including 90 percent of the Fortune 500, rely on products, solutions, services and data from Pitney Bowes in the areas of customer information management, location intelligence, customer engagement, shipping, mailing, and global ecommerce. And with the innovative Pitney Bowes Commerce Cloud, clients can access the broad range of Pitney Bowes solutions, analytics, and APIs to drive commerce. For additional information visit Pitney Bowes, the Craftsmen of Commerce, at www.pitneybowes.com/uk.

Contact information

Pitney Bowes
Anne Amlot
Anne.amlot@pb.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13Pressemelding

Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in

Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34Pressemelding

Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712

Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21Pressemelding

Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr

Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38Pressemelding

A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L

Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00Pressemelding

Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a

AML BitCoin Enters Phase II of ICO15.12.2017 09:00Pressemelding

NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom